Markets & Future Prospects for Cell & Gene Therapy

\r\n The enormous number of companies involved in Cell Therapy has increased progression remarkably during the past few years. More than 500 companies have been identified to be involved in cell therapy and 305 of these are profiled 291 alliances. Of these companies, 170 are involved in stem cells. The Profiles of 72 academic institutions in the US involved in cell therapy along with their commercial collaborations. Allogeneic technology with more than 350 clinical trials is poised to dominate the commercialization of cell therapies in market. Further RandD in cell and gene therapy is expected to bloom given the biologically based advantages.

\r\n

\r\n  

\r\n

    Related Conference of Markets & Future Prospects for Cell & Gene Therapy

    Markets & Future Prospects for Cell & Gene Therapy Conference Speakers